JP2009519720A5 - - Google Patents

Info

Publication number

JP2009519720A5

JP2009519720A5 JP2008546030A JP2008546030A JP2009519720A5 JP 2009519720 A5 JP2009519720 A5 JP 2009519720A5 JP 2008546030 A JP2008546030 A JP 2008546030A JP 2008546030 A JP2008546030 A JP 2008546030A JP 2009519720 A5 JP2009519720 A5 JP 2009519720A5

Authority

JP

Japan

Prior art keywords

seq

dab

recombinant

disease

sequence

Prior art date

2006-12-20

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 17
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 claims description 8
• 102000057041 human TNF Human genes 0.000 claims description 6
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
• 108060003951 Immunoglobulin Proteins 0.000 claims description 3
• 241000288935 Platyrrhini Species 0.000 claims description 3
• 102000018358 immunoglobulin Human genes 0.000 claims description 3
• 238000000034 method Methods 0.000 claims 4
• 206010040070 Septic Shock Diseases 0.000 claims 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
• 239000000523 sample Substances 0.000 claims 3
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 2
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 claims 2
• 206010040047 Sepsis Diseases 0.000 claims 2
• 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 2
• 201000010099 disease Diseases 0.000 claims 2
• 230000000694 effects Effects 0.000 claims 2
• 208000015181 infectious disease Diseases 0.000 claims 2
• 208000027866 inflammatory disease Diseases 0.000 claims 2
• 239000008194 pharmaceutical composition Substances 0.000 claims 2
• 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
• 208000020084 Bone disease Diseases 0.000 claims 1
• 206010006895 Cachexia Diseases 0.000 claims 1
• 206010053567 Coagulopathies Diseases 0.000 claims 1
• 206010009900 Colitis ulcerative Diseases 0.000 claims 1
• 208000035473 Communicable disease Diseases 0.000 claims 1
• 208000011231 Crohn disease Diseases 0.000 claims 1
• 206010014824 Endotoxic shock Diseases 0.000 claims 1
• 201000005569 Gout Diseases 0.000 claims 1
• 206010018634 Gouty Arthritis Diseases 0.000 claims 1
• 241000282412 Homo Species 0.000 claims 1
• 206010020751 Hypersensitivity Diseases 0.000 claims 1
• 206010061218 Inflammation Diseases 0.000 claims 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
• 206010023330 Keloid scar Diseases 0.000 claims 1
• 208000019693 Lung disease Diseases 0.000 claims 1
• 206010027476 Metastases Diseases 0.000 claims 1
• 208000021642 Muscular disease Diseases 0.000 claims 1
• 201000009623 Myopathy Diseases 0.000 claims 1
• 206010029164 Nephrotic syndrome Diseases 0.000 claims 1
• 206010037660 Pyrexia Diseases 0.000 claims 1
• 206010063837 Reperfusion injury Diseases 0.000 claims 1
• 201000010001 Silicosis Diseases 0.000 claims 1
• 206010044248 Toxic shock syndrome Diseases 0.000 claims 1
• 231100000650 Toxic shock syndrome Toxicity 0.000 claims 1
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
• 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
• 208000011341 adult acute respiratory distress syndrome Diseases 0.000 claims 1
• 230000007815 allergy Effects 0.000 claims 1
• 239000000427 antigen Substances 0.000 claims 1
• 102000036639 antigens Human genes 0.000 claims 1
• 108091007433 antigens Proteins 0.000 claims 1
• 201000004982 autoimmune uveitis Diseases 0.000 claims 1
• 230000005784 autoimmunity Effects 0.000 claims 1
• 239000012472 biological sample Substances 0.000 claims 1
• 208000015294 blood coagulation disease Diseases 0.000 claims 1
• 230000001684 chronic effect Effects 0.000 claims 1
• 239000003085 diluting agent Substances 0.000 claims 1
• 239000003937 drug carrier Substances 0.000 claims 1
• 208000019622 heart disease Diseases 0.000 claims 1
• 208000006454 hepatitis Diseases 0.000 claims 1
• 231100000283 hepatitis Toxicity 0.000 claims 1
• 230000005847 immunogenicity Effects 0.000 claims 1
• 230000002757 inflammatory effect Effects 0.000 claims 1
• 230000004054 inflammatory process Effects 0.000 claims 1
• 208000011379 keloid formation Diseases 0.000 claims 1
• 230000009401 metastasis Effects 0.000 claims 1
• 201000006417 multiple sclerosis Diseases 0.000 claims 1
• 150000007523 nucleic acids Chemical class 0.000 claims 1
• 102000039446 nucleic acids Human genes 0.000 claims 1
• 108020004707 nucleic acids Proteins 0.000 claims 1
• 201000008482 osteoarthritis Diseases 0.000 claims 1
• 230000002685 pulmonary effect Effects 0.000 claims 1
• 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
• 201000003651 pulmonary sarcoidosis Diseases 0.000 claims 1
• 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
• 231100000241 scar Toxicity 0.000 claims 1
• 230000036303 septic shock Effects 0.000 claims 1
• 208000013223 septicemia Diseases 0.000 claims 1
• 230000009772 tissue formation Effects 0.000 claims 1
• 230000004614 tumor growth Effects 0.000 claims 1
• 241000282709 Aotus trivirgatus Species 0.000 description 6
• 241001515942 marmosets Species 0.000 description 6
• 150000001413 amino acids Chemical group 0.000 description 5
• 102100035361 Cerebellar degeneration-related protein 2 Human genes 0.000 description 4
• 101000737796 Homo sapiens Cerebellar degeneration-related protein 2 Proteins 0.000 description 4
• 150000001875 compounds Chemical class 0.000 description 4
• 239000002773 nucleotide Substances 0.000 description 4
• 125000003729 nucleotide group Chemical group 0.000 description 4
• 102100040247 Tumor necrosis factor Human genes 0.000 description 2
• 241000282708 Aotus <primate> Species 0.000 description 1
• 241001502973 Aotus nancymaae Species 0.000 description 1
• 108091034117 Oligonucleotide Proteins 0.000 description 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 108090000623 proteins and genes Proteins 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1